ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global AL Amyloidosis Therapeutics Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-5O13995
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global AL Amyloidosis Therapeutics Market Research Report 2023
BUY CHAPTERS

Global AL Amyloidosis Therapeutics Market Research Report 2025

Code: QYRE-Auto-5O13995
Report
May 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Janssen Pharmaceutical
Prothena
Alexion Pharmaceuticals
Oncopeptides
Bristol–Myers Squibb
GlaxoSmithKline Pharmaceuticals Ltd
Eidos Therapeutics, Inc
Corino Therapeutics, Inc
Spectrum Pharmaceuticals Inc
Pfizer Inc

AL Amyloidosis Therapeutics Market Size

The global market for AL Amyloidosis Therapeutics was valued at US$ 2398 million in the year 2024 and is projected to reach a revised size of US$ 3900 million by 2031, growing at a CAGR of 7.3% during the forecast period.

AL Amyloidosis Therapeutics Market

AL Amyloidosis Therapeutics Market

The most common kind of systemic amyloidosis is the amyloid light chain (AL) amyloidosis, sometimes referred to as primary amyloidosis. Systemic light-chain (AL) amyloidosis was once thought to be an unstoppable deadly condition.
The AL amyloidosis therapeutics market is driven by the increasing awareness of the disease and advances in medical research. AL amyloidosis is a rare and life-threatening condition caused by the deposition of abnormal proteins in tissues and organs. The rise in diagnostic capabilities and the growing understanding of the disease"s pathophysiology have led to the development of targeted therapies, driving market growth. Moreover, the emergence of novel treatment options, such as monoclonal antibodies and proteasome inhibitors, has significantly improved patient outcomes. However, the market also faces challenges, including the rarity of the disease, making clinical trials and drug development more challenging. Additionally, the need for early and accurate diagnosis and the high cost of specialized therapies pose obstacles for both patients and healthcare systems. To succeed, companies must invest in research and development, collaborate with healthcare providers to improve disease awareness and diagnosis, and work towards making AL amyloidosis therapeutics more accessible and affordable for patients in need.
This report aims to provide a comprehensive presentation of the global market for AL Amyloidosis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AL Amyloidosis Therapeutics.
The AL Amyloidosis Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global AL Amyloidosis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the AL Amyloidosis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of AL Amyloidosis Therapeutics Market Report

Report Metric Details
Report Name AL Amyloidosis Therapeutics Market
Accounted market size in year US$ 2398 million
Forecasted market size in 2031 US$ 3900 million
CAGR 7.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Janssen Pharmaceutical, Prothena, Alexion Pharmaceuticals, Oncopeptides AB, Bristol-Myers Squibb, GlaxoSmithKline Pharmaceuticals Ltd, Eidos Therapeutics, Inc., Corino Therapeutics, Inc., Spectrum Pharmaceuticals, Inc., Pfizer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of AL Amyloidosis Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is AL Amyloidosis Therapeutics Market growing?

Ans: The AL Amyloidosis Therapeutics Market witnessing a CAGR of 7.3% during the forecast period 2025-2031.

What is the AL Amyloidosis Therapeutics Market size in 2031?

Ans: The AL Amyloidosis Therapeutics Market size in 2031 will be US$ 3900 million.

Who are the main players in the AL Amyloidosis Therapeutics Market report?

Ans: The main players in the AL Amyloidosis Therapeutics Market are Janssen Pharmaceutical, Prothena, Alexion Pharmaceuticals, Oncopeptides AB, Bristol-Myers Squibb, GlaxoSmithKline Pharmaceuticals Ltd, Eidos Therapeutics, Inc., Corino Therapeutics, Inc., Spectrum Pharmaceuticals, Inc., Pfizer

What are the Application segmentation covered in the AL Amyloidosis Therapeutics Market report?

Ans: The Applications covered in the AL Amyloidosis Therapeutics Market report are Hospitals, Clinics, Ambulatory Service Centres, Others

What are the Type segmentation covered in the AL Amyloidosis Therapeutics Market report?

Ans: The Types covered in the AL Amyloidosis Therapeutics Market report are Chemotherapy, Supportive Care, Surgery, Stem Cell Transplant, Targeted Therapy

Recommended Reports

Amyloidosis & Related

Rare Disease Therapy

Blood & Lymphatic Cancers

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global AL Amyloidosis Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Chemotherapy
1.2.3 Supportive Care
1.2.4 Surgery
1.2.5 Stem Cell Transplant
1.2.6 Targeted Therapy
1.3 Market by Application
1.3.1 Global AL Amyloidosis Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Service Centres
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global AL Amyloidosis Therapeutics Market Perspective (2020-2031)
2.2 Global AL Amyloidosis Therapeutics Growth Trends by Region
2.2.1 Global AL Amyloidosis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 AL Amyloidosis Therapeutics Historic Market Size by Region (2020-2025)
2.2.3 AL Amyloidosis Therapeutics Forecasted Market Size by Region (2026-2031)
2.3 AL Amyloidosis Therapeutics Market Dynamics
2.3.1 AL Amyloidosis Therapeutics Industry Trends
2.3.2 AL Amyloidosis Therapeutics Market Drivers
2.3.3 AL Amyloidosis Therapeutics Market Challenges
2.3.4 AL Amyloidosis Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top AL Amyloidosis Therapeutics Players by Revenue
3.1.1 Global Top AL Amyloidosis Therapeutics Players by Revenue (2020-2025)
3.1.2 Global AL Amyloidosis Therapeutics Revenue Market Share by Players (2020-2025)
3.2 Global AL Amyloidosis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by AL Amyloidosis Therapeutics Revenue
3.4 Global AL Amyloidosis Therapeutics Market Concentration Ratio
3.4.1 Global AL Amyloidosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by AL Amyloidosis Therapeutics Revenue in 2024
3.5 Global Key Players of AL Amyloidosis Therapeutics Head office and Area Served
3.6 Global Key Players of AL Amyloidosis Therapeutics, Product and Application
3.7 Global Key Players of AL Amyloidosis Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 AL Amyloidosis Therapeutics Breakdown Data by Type
4.1 Global AL Amyloidosis Therapeutics Historic Market Size by Type (2020-2025)
4.2 Global AL Amyloidosis Therapeutics Forecasted Market Size by Type (2026-2031)
5 AL Amyloidosis Therapeutics Breakdown Data by Application
5.1 Global AL Amyloidosis Therapeutics Historic Market Size by Application (2020-2025)
5.2 Global AL Amyloidosis Therapeutics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America AL Amyloidosis Therapeutics Market Size (2020-2031)
6.2 North America AL Amyloidosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America AL Amyloidosis Therapeutics Market Size by Country (2020-2025)
6.4 North America AL Amyloidosis Therapeutics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe AL Amyloidosis Therapeutics Market Size (2020-2031)
7.2 Europe AL Amyloidosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe AL Amyloidosis Therapeutics Market Size by Country (2020-2025)
7.4 Europe AL Amyloidosis Therapeutics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific AL Amyloidosis Therapeutics Market Size (2020-2031)
8.2 Asia-Pacific AL Amyloidosis Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific AL Amyloidosis Therapeutics Market Size by Region (2020-2025)
8.4 Asia-Pacific AL Amyloidosis Therapeutics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America AL Amyloidosis Therapeutics Market Size (2020-2031)
9.2 Latin America AL Amyloidosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America AL Amyloidosis Therapeutics Market Size by Country (2020-2025)
9.4 Latin America AL Amyloidosis Therapeutics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa AL Amyloidosis Therapeutics Market Size (2020-2031)
10.2 Middle East & Africa AL Amyloidosis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa AL Amyloidosis Therapeutics Market Size by Country (2020-2025)
10.4 Middle East & Africa AL Amyloidosis Therapeutics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Janssen Pharmaceutical
11.1.1 Janssen Pharmaceutical Company Details
11.1.2 Janssen Pharmaceutical Business Overview
11.1.3 Janssen Pharmaceutical AL Amyloidosis Therapeutics Introduction
11.1.4 Janssen Pharmaceutical Revenue in AL Amyloidosis Therapeutics Business (2020-2025)
11.1.5 Janssen Pharmaceutical Recent Development
11.2 Prothena
11.2.1 Prothena Company Details
11.2.2 Prothena Business Overview
11.2.3 Prothena AL Amyloidosis Therapeutics Introduction
11.2.4 Prothena Revenue in AL Amyloidosis Therapeutics Business (2020-2025)
11.2.5 Prothena Recent Development
11.3 Alexion Pharmaceuticals
11.3.1 Alexion Pharmaceuticals Company Details
11.3.2 Alexion Pharmaceuticals Business Overview
11.3.3 Alexion Pharmaceuticals AL Amyloidosis Therapeutics Introduction
11.3.4 Alexion Pharmaceuticals Revenue in AL Amyloidosis Therapeutics Business (2020-2025)
11.3.5 Alexion Pharmaceuticals Recent Development
11.4 Oncopeptides AB
11.4.1 Oncopeptides AB Company Details
11.4.2 Oncopeptides AB Business Overview
11.4.3 Oncopeptides AB AL Amyloidosis Therapeutics Introduction
11.4.4 Oncopeptides AB Revenue in AL Amyloidosis Therapeutics Business (2020-2025)
11.4.5 Oncopeptides AB Recent Development
11.5 Bristol-Myers Squibb
11.5.1 Bristol-Myers Squibb Company Details
11.5.2 Bristol-Myers Squibb Business Overview
11.5.3 Bristol-Myers Squibb AL Amyloidosis Therapeutics Introduction
11.5.4 Bristol-Myers Squibb Revenue in AL Amyloidosis Therapeutics Business (2020-2025)
11.5.5 Bristol-Myers Squibb Recent Development
11.6 GlaxoSmithKline Pharmaceuticals Ltd
11.6.1 GlaxoSmithKline Pharmaceuticals Ltd Company Details
11.6.2 GlaxoSmithKline Pharmaceuticals Ltd Business Overview
11.6.3 GlaxoSmithKline Pharmaceuticals Ltd AL Amyloidosis Therapeutics Introduction
11.6.4 GlaxoSmithKline Pharmaceuticals Ltd Revenue in AL Amyloidosis Therapeutics Business (2020-2025)
11.6.5 GlaxoSmithKline Pharmaceuticals Ltd Recent Development
11.7 Eidos Therapeutics, Inc.
11.7.1 Eidos Therapeutics, Inc. Company Details
11.7.2 Eidos Therapeutics, Inc. Business Overview
11.7.3 Eidos Therapeutics, Inc. AL Amyloidosis Therapeutics Introduction
11.7.4 Eidos Therapeutics, Inc. Revenue in AL Amyloidosis Therapeutics Business (2020-2025)
11.7.5 Eidos Therapeutics, Inc. Recent Development
11.8 Corino Therapeutics, Inc.
11.8.1 Corino Therapeutics, Inc. Company Details
11.8.2 Corino Therapeutics, Inc. Business Overview
11.8.3 Corino Therapeutics, Inc. AL Amyloidosis Therapeutics Introduction
11.8.4 Corino Therapeutics, Inc. Revenue in AL Amyloidosis Therapeutics Business (2020-2025)
11.8.5 Corino Therapeutics, Inc. Recent Development
11.9 Spectrum Pharmaceuticals, Inc.
11.9.1 Spectrum Pharmaceuticals, Inc. Company Details
11.9.2 Spectrum Pharmaceuticals, Inc. Business Overview
11.9.3 Spectrum Pharmaceuticals, Inc. AL Amyloidosis Therapeutics Introduction
11.9.4 Spectrum Pharmaceuticals, Inc. Revenue in AL Amyloidosis Therapeutics Business (2020-2025)
11.9.5 Spectrum Pharmaceuticals, Inc. Recent Development
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer AL Amyloidosis Therapeutics Introduction
11.10.4 Pfizer Revenue in AL Amyloidosis Therapeutics Business (2020-2025)
11.10.5 Pfizer Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Janssen Pharmaceutical
Prothena
Alexion Pharmaceuticals
Oncopeptides
Bristol–Myers Squibb
GlaxoSmithKline Pharmaceuticals Ltd
Eidos Therapeutics, Inc
Corino Therapeutics, Inc
Spectrum Pharmaceuticals Inc
Pfizer Inc
List of Tables
 Table 1. Global AL Amyloidosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Chemotherapy
 Table 3. Key Players of Supportive Care
 Table 4. Key Players of Surgery
 Table 5. Key Players of Stem Cell Transplant
 Table 6. Key Players of Targeted Therapy
 Table 7. Global AL Amyloidosis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global AL Amyloidosis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 9. Global AL Amyloidosis Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 10. Global AL Amyloidosis Therapeutics Market Share by Region (2020-2025)
 Table 11. Global AL Amyloidosis Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 12. Global AL Amyloidosis Therapeutics Market Share by Region (2026-2031)
 Table 13. AL Amyloidosis Therapeutics Market Trends
 Table 14. AL Amyloidosis Therapeutics Market Drivers
 Table 15. AL Amyloidosis Therapeutics Market Challenges
 Table 16. AL Amyloidosis Therapeutics Market Restraints
 Table 17. Global AL Amyloidosis Therapeutics Revenue by Players (2020-2025) & (US$ Million)
 Table 18. Global AL Amyloidosis Therapeutics Market Share by Players (2020-2025)
 Table 19. Global Top AL Amyloidosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AL Amyloidosis Therapeutics as of 2024)
 Table 20. Ranking of Global Top AL Amyloidosis Therapeutics Companies by Revenue (US$ Million) in 2024
 Table 21. Global 5 Largest Players Market Share by AL Amyloidosis Therapeutics Revenue (CR5 and HHI) & (2020-2025)
 Table 22. Global Key Players of AL Amyloidosis Therapeutics, Headquarters and Area Served
 Table 23. Global Key Players of AL Amyloidosis Therapeutics, Product and Application
 Table 24. Global Key Players of AL Amyloidosis Therapeutics, Date of Enter into This Industry
 Table 25. Mergers & Acquisitions, Expansion Plans
 Table 26. Global AL Amyloidosis Therapeutics Market Size by Type (2020-2025) & (US$ Million)
 Table 27. Global AL Amyloidosis Therapeutics Revenue Market Share by Type (2020-2025)
 Table 28. Global AL Amyloidosis Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 29. Global AL Amyloidosis Therapeutics Revenue Market Share by Type (2026-2031)
 Table 30. Global AL Amyloidosis Therapeutics Market Size by Application (2020-2025) & (US$ Million)
 Table 31. Global AL Amyloidosis Therapeutics Revenue Market Share by Application (2020-2025)
 Table 32. Global AL Amyloidosis Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 33. Global AL Amyloidosis Therapeutics Revenue Market Share by Application (2026-2031)
 Table 34. North America AL Amyloidosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. North America AL Amyloidosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 36. North America AL Amyloidosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Europe AL Amyloidosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Europe AL Amyloidosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 39. Europe AL Amyloidosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 40. Asia-Pacific AL Amyloidosis Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Asia-Pacific AL Amyloidosis Therapeutics Market Size by Region (2020-2025) & (US$ Million)
 Table 42. Asia-Pacific AL Amyloidosis Therapeutics Market Size by Region (2026-2031) & (US$ Million)
 Table 43. Latin America AL Amyloidosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Latin America AL Amyloidosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Latin America AL Amyloidosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Middle East & Africa AL Amyloidosis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 47. Middle East & Africa AL Amyloidosis Therapeutics Market Size by Country (2020-2025) & (US$ Million)
 Table 48. Middle East & Africa AL Amyloidosis Therapeutics Market Size by Country (2026-2031) & (US$ Million)
 Table 49. Janssen Pharmaceutical Company Details
 Table 50. Janssen Pharmaceutical Business Overview
 Table 51. Janssen Pharmaceutical AL Amyloidosis Therapeutics Product
 Table 52. Janssen Pharmaceutical Revenue in AL Amyloidosis Therapeutics Business (2020-2025) & (US$ Million)
 Table 53. Janssen Pharmaceutical Recent Development
 Table 54. Prothena Company Details
 Table 55. Prothena Business Overview
 Table 56. Prothena AL Amyloidosis Therapeutics Product
 Table 57. Prothena Revenue in AL Amyloidosis Therapeutics Business (2020-2025) & (US$ Million)
 Table 58. Prothena Recent Development
 Table 59. Alexion Pharmaceuticals Company Details
 Table 60. Alexion Pharmaceuticals Business Overview
 Table 61. Alexion Pharmaceuticals AL Amyloidosis Therapeutics Product
 Table 62. Alexion Pharmaceuticals Revenue in AL Amyloidosis Therapeutics Business (2020-2025) & (US$ Million)
 Table 63. Alexion Pharmaceuticals Recent Development
 Table 64. Oncopeptides AB Company Details
 Table 65. Oncopeptides AB Business Overview
 Table 66. Oncopeptides AB AL Amyloidosis Therapeutics Product
 Table 67. Oncopeptides AB Revenue in AL Amyloidosis Therapeutics Business (2020-2025) & (US$ Million)
 Table 68. Oncopeptides AB Recent Development
 Table 69. Bristol-Myers Squibb Company Details
 Table 70. Bristol-Myers Squibb Business Overview
 Table 71. Bristol-Myers Squibb AL Amyloidosis Therapeutics Product
 Table 72. Bristol-Myers Squibb Revenue in AL Amyloidosis Therapeutics Business (2020-2025) & (US$ Million)
 Table 73. Bristol-Myers Squibb Recent Development
 Table 74. GlaxoSmithKline Pharmaceuticals Ltd Company Details
 Table 75. GlaxoSmithKline Pharmaceuticals Ltd Business Overview
 Table 76. GlaxoSmithKline Pharmaceuticals Ltd AL Amyloidosis Therapeutics Product
 Table 77. GlaxoSmithKline Pharmaceuticals Ltd Revenue in AL Amyloidosis Therapeutics Business (2020-2025) & (US$ Million)
 Table 78. GlaxoSmithKline Pharmaceuticals Ltd Recent Development
 Table 79. Eidos Therapeutics, Inc. Company Details
 Table 80. Eidos Therapeutics, Inc. Business Overview
 Table 81. Eidos Therapeutics, Inc. AL Amyloidosis Therapeutics Product
 Table 82. Eidos Therapeutics, Inc. Revenue in AL Amyloidosis Therapeutics Business (2020-2025) & (US$ Million)
 Table 83. Eidos Therapeutics, Inc. Recent Development
 Table 84. Corino Therapeutics, Inc. Company Details
 Table 85. Corino Therapeutics, Inc. Business Overview
 Table 86. Corino Therapeutics, Inc. AL Amyloidosis Therapeutics Product
 Table 87. Corino Therapeutics, Inc. Revenue in AL Amyloidosis Therapeutics Business (2020-2025) & (US$ Million)
 Table 88. Corino Therapeutics, Inc. Recent Development
 Table 89. Spectrum Pharmaceuticals, Inc. Company Details
 Table 90. Spectrum Pharmaceuticals, Inc. Business Overview
 Table 91. Spectrum Pharmaceuticals, Inc. AL Amyloidosis Therapeutics Product
 Table 92. Spectrum Pharmaceuticals, Inc. Revenue in AL Amyloidosis Therapeutics Business (2020-2025) & (US$ Million)
 Table 93. Spectrum Pharmaceuticals, Inc. Recent Development
 Table 94. Pfizer Company Details
 Table 95. Pfizer Business Overview
 Table 96. Pfizer AL Amyloidosis Therapeutics Product
 Table 97. Pfizer Revenue in AL Amyloidosis Therapeutics Business (2020-2025) & (US$ Million)
 Table 98. Pfizer Recent Development
 Table 99. Research Programs/Design for This Report
 Table 100. Key Data Information from Secondary Sources
 Table 101. Key Data Information from Primary Sources
 Table 102. Authors List of This Report


List of Figures
 Figure 1. AL Amyloidosis Therapeutics Picture
 Figure 2. Global AL Amyloidosis Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global AL Amyloidosis Therapeutics Market Share by Type: 2024 VS 2031
 Figure 4. Chemotherapy Features
 Figure 5. Supportive Care Features
 Figure 6. Surgery Features
 Figure 7. Stem Cell Transplant Features
 Figure 8. Targeted Therapy Features
 Figure 9. Global AL Amyloidosis Therapeutics Market Size by Application (2020-2031) & (US$ Million)
 Figure 10. Global AL Amyloidosis Therapeutics Market Share by Application: 2024 VS 2031
 Figure 11. Hospitals Case Studies
 Figure 12. Clinics Case Studies
 Figure 13. Ambulatory Service Centres Case Studies
 Figure 14. Others Case Studies
 Figure 15. AL Amyloidosis Therapeutics Report Years Considered
 Figure 16. Global AL Amyloidosis Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global AL Amyloidosis Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global AL Amyloidosis Therapeutics Market Share by Region: 2024 VS 2031
 Figure 19. Global AL Amyloidosis Therapeutics Market Share by Players in 2024
 Figure 20. Global Top AL Amyloidosis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AL Amyloidosis Therapeutics as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by AL Amyloidosis Therapeutics Revenue in 2024
 Figure 22. North America AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America AL Amyloidosis Therapeutics Market Share by Country (2020-2031)
 Figure 24. United States AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe AL Amyloidosis Therapeutics Market Share by Country (2020-2031)
 Figure 28. Germany AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific AL Amyloidosis Therapeutics Market Share by Region (2020-2031)
 Figure 36. China AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America AL Amyloidosis Therapeutics Market Share by Country (2020-2031)
 Figure 44. Mexico AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa AL Amyloidosis Therapeutics Market Share by Country (2020-2031)
 Figure 48. Turkey AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE AL Amyloidosis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Janssen Pharmaceutical Revenue Growth Rate in AL Amyloidosis Therapeutics Business (2020-2025)
 Figure 52. Prothena Revenue Growth Rate in AL Amyloidosis Therapeutics Business (2020-2025)
 Figure 53. Alexion Pharmaceuticals Revenue Growth Rate in AL Amyloidosis Therapeutics Business (2020-2025)
 Figure 54. Oncopeptides AB Revenue Growth Rate in AL Amyloidosis Therapeutics Business (2020-2025)
 Figure 55. Bristol-Myers Squibb Revenue Growth Rate in AL Amyloidosis Therapeutics Business (2020-2025)
 Figure 56. GlaxoSmithKline Pharmaceuticals Ltd Revenue Growth Rate in AL Amyloidosis Therapeutics Business (2020-2025)
 Figure 57. Eidos Therapeutics, Inc. Revenue Growth Rate in AL Amyloidosis Therapeutics Business (2020-2025)
 Figure 58. Corino Therapeutics, Inc. Revenue Growth Rate in AL Amyloidosis Therapeutics Business (2020-2025)
 Figure 59. Spectrum Pharmaceuticals, Inc. Revenue Growth Rate in AL Amyloidosis Therapeutics Business (2020-2025)
 Figure 60. Pfizer Revenue Growth Rate in AL Amyloidosis Therapeutics Business (2020-2025)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Systemic Amyloidosis Market Research Report 2024
Hereditary Amyloidosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Amyloidosis Therapeutics Market Research Report 2024
Transthyretin Amyloidosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti amyloid Therapy Market Research Report 2024
Transthyretin amyloid cardiomyopathy ATTR CM Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Alzheimer s Disease Therapeutics and Diagnostics Market Insights Forecast to 2030
Global Alzheimer s Disease Drug Market Insights Forecast to 2030
Global Lupus Therapeutic Market Research Report 2024
Global Anti amyloid Drugs Market Research Report 2024
Global Alzheimer Treatment Drug Market Research Report 2025
Global Cryoglobulinemia Treatment Market Research Report 2025
Global Demyelinating Diseases Therapeutics Market Research Report 2024
Global Blood based Detection Kit for Early Diagnosis of Alzheimer s Disease Market Research Report 2024
Global Alzheimer s Disease Treatments Market Research Report 2024
Acute Lymphoblastic Leukemia Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Dementia and Alzheimer s Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Systemic Sclerosis Treatments Market Research Report 2024
Global Alzheimer s Disease Blood Test Kit Market Research Report 2024
Global Arteriosclerosis Therapeutics Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions